Three Cornell undergraduates are recipients of this year’s Robinson-Appel Humanitarian Awards, which recognize students for their commitment to community-engaged work addressing pressing social challenges.
Weill Cornell Medicine investigators made an unexpected finding that could open new avenues for therapies against inflammatory bowel disease, food allergy and other autoimmune conditions.
Researchers at Cornell University have developed a powerful new genetic toolkit that allows scientists to study how genes function at the level of individual cells, an advance that could accelerate discoveries in development, neuroscience and disease.
Weill Cornell Medicine researchers have demonstrated, for the first time, that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.”
State laws that ban insurance prior authorization for buprenorphine, used for opioid use disorder, may not help more patients stay in treatment for the recommended 180 days, Weill Cornell Medicine researchers report.
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.
Thirty student startups received Human Spirit, Beck Fellows and Cane Entrepreneurial Scholars awards this summer from Entrepreneurship at Cornell, funding that will allow students to work on their startups rather than take traditional summer positions.
The class of 2026 learned on March 20 where they will be doing their internship and residency training, setting the stage for the next several years of their medical careers and lives.